Limited coverage drugs – etanercept

Generic name

etanercept

Strength

25 mg, 50 mg

Form

• Brenzys®—50 mg solution for injection in a pre-filled syringe or pre-filled auto-injector
• Erelzi™—25 mg and 50 mg solution for injection in a pre-filled syringe, 50 mg pre-filled auto-injector

 Special Authority criteria

 Approval period

1. Treatment of rheumatoid arthritis according to established criteria* when prescribed by a rheumatologist

•  First approval: 1 year
•  Renewal: 1 year to indefinite

2. Treatment of ankylosing spondylitis according to established criteria* when prescribed by a rheumatologist

• First approval: 1 year
• Renewal: 1 year to indefinite

3. Treatment of psoriatic arthritis according to established criteria* when prescribed by a rheumatologist

• First approval: 1 year
• Renewal: 1 year to indefinite

4. Treatment of moderate to severe active polyarticular juvenile idiopathic arthritis (pJIA) for patients 4 years and older, who, due to intolerance or lack of efficacy, have not adequately responded to methotrexate

• First approval: 1 year
• Renewal: 1 year to indefinite

5. Treatment of moderate to severe plaque psoriasis according to established criteria* when prescribed by a dermatologist

• First approval: 12 weeks
• Renewal: 1 year